Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001177719-26-000008·Ascendis Pharma A/S
Schedule 13G ownership disclosure
ASCENDIS PHARMA A/S
Common Stock · CUSIP: 04351P101
Event date: 2025-12-31
- Filing-level shares
- 5,185,696
- Percent of class
- 8.48%
- Westfield Capital Management Company, L.P.
Shares: 5,185,696 · Class: 8.48%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001177719-26-000008
- Form type
- SCHEDULE 13G/A
- Filer
- Ascendis Pharma A/S
- CIK
- CIK 1612042
- Filed
- Feb 11, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership